196 related articles for article (PubMed ID: 36563921)
1. Effects of cannabinoids on resting state functional brain connectivity: A systematic review.
Lorenzetti V; Gaillard A; Thomson D; Englund A; Freeman TP
Neurosci Biobehav Rev; 2023 Feb; 145():105014. PubMed ID: 36563921
[TBL] [Abstract][Full Text] [Related]
2. Individual and combined effects of cannabidiol and Δ
Wall MB; Freeman TP; Hindocha C; Demetriou L; Ertl N; Freeman AM; Jones AP; Lawn W; Pope R; Mokrysz C; Solomons D; Statton B; Walker HR; Yamamori Y; Yang Z; Yim JL; Nutt DJ; Howes OD; Curran HV; Bloomfield MA
J Psychopharmacol; 2022 Jun; 36(6):732-744. PubMed ID: 35596578
[TBL] [Abstract][Full Text] [Related]
3. Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity.
Wall MB; Pope R; Freeman TP; Kowalczyk OS; Demetriou L; Mokrysz C; Hindocha C; Lawn W; Bloomfield MA; Freeman AM; Feilding A; Nutt D; Curran HV
J Psychopharmacol; 2019 Jul; 33(7):822-830. PubMed ID: 31013455
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid modulation of functional connectivity within regions processing attentional salience.
Bhattacharyya S; Falkenberg I; Martin-Santos R; Atakan Z; Crippa JA; Giampietro V; Brammer M; McGuire P
Neuropsychopharmacology; 2015 May; 40(6):1343-52. PubMed ID: 25249057
[TBL] [Abstract][Full Text] [Related]
5. Effect of Δ9-Tetrahydrocannabinol on frontostriatal resting state functional connectivity and subjective euphoric response in healthy young adults.
Crane NA; Phan KL
Drug Alcohol Depend; 2021 Apr; 221():108565. PubMed ID: 33592558
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of Δ
Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N
Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
[TBL] [Abstract][Full Text] [Related]
8. Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior.
Ganesh S; Cortes-Briones J; Schnakenberg Martin AM; Skosnik PD; D'Souza DC; Ranganathan M
Cannabis Cannabinoid Res; 2023 Oct; 8(5):846-856. PubMed ID: 35319274
[No Abstract] [Full Text] [Related]
9. The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ
Gunasekera B; Davies C; Martin-Santos R; Bhattacharyya S
Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):636-645. PubMed ID: 33414100
[TBL] [Abstract][Full Text] [Related]
10. Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity.
Grimm O; Löffler M; Kamping S; Hartmann A; Rohleder C; Leweke M; Flor H
Eur Neuropsychopharmacol; 2018 Jul; 28(7):841-849. PubMed ID: 29887287
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid Exposure and Subjective Effects of THC and CBD in Edible Cannabis Products.
Gibson LP; Mueller RL; Winiger EA; Klawitter J; Sempio C; Williams S; Bryan AD; Bidwell LC; Hutchison KE
Cannabis Cannabinoid Res; 2024 Feb; 9(1):320-334. PubMed ID: 36378267
[No Abstract] [Full Text] [Related]
12. The Effects of Cannabidiol and δ-9-Tetrahydrocannabinol in Social Cognition: A Naturalistic Controlled Study.
Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
Cannabis Cannabinoid Res; 2024 Feb; 9(1):230-240. PubMed ID: 35881851
[No Abstract] [Full Text] [Related]
13. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence.
Chye Y; Kirkham R; Lorenzetti V; McTavish E; Solowij N; Yücel M
Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):627-635. PubMed ID: 32948510
[TBL] [Abstract][Full Text] [Related]
14. Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite.
Spanagel R; Bilbao A
Neuropharmacology; 2021 Sep; 196():108680. PubMed ID: 34181977
[TBL] [Abstract][Full Text] [Related]
15. Behavioral Effects of Vaporized Delta-8 Tetrahydrocannabinol, Cannabidiol, and Mixtures in Male Rats.
Durbin DJ; King JM; Stairs DJ
Cannabis Cannabinoid Res; 2024 Apr; 9(2):601-611. PubMed ID: 36802211
[No Abstract] [Full Text] [Related]
16. Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses.
Lawn W; Freeman TP; Pope RA; Joye A; Harvey L; Hindocha C; Mokrysz C; Moss A; Wall MB; Bloomfield MA; Das RK; Morgan CJ; Nutt DJ; Curran HV
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3537-52. PubMed ID: 27585792
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid use is enhanced by stress and changes conditioned stress responses.
Hodebourg R; Meyerink ME; Crow AD; Reichel CM; Kalivas PW; Garcia-Keller C
Neuropsychopharmacology; 2022 Apr; 47(5):1037-1045. PubMed ID: 35145212
[TBL] [Abstract][Full Text] [Related]
18. Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.
Allendorfer JB; Szaflarski JP
Epilepsy Behav; 2017 May; 70(Pt B):349-354. PubMed ID: 28109780
[TBL] [Abstract][Full Text] [Related]
19. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
Liu Z; Galettis P; Broyd SJ; van Hell H; Greenwood LM; de Krey P; Steigler A; Zhu X; Schneider J; Solowij N; Martin JH
Intern Med J; 2020 Jul; 50(7):846-853. PubMed ID: 31264294
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study.
Kayser RR; Haney M; Raskin M; Arout C; Simpson HB
Depress Anxiety; 2020 Aug; 37(8):801-811. PubMed ID: 32383271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
